Pseudoprogression of brain tumors

SC Thust, MJ van den Bent… - Journal of Magnetic …, 2018 - Wiley Online Library
This review describes the definition, incidence, clinical implications, and magnetic
resonance imaging (MRI) findings of pseudoprogression of brain tumors, in particular, but …

MRI-only treatment planning: benefits and challenges

AM Owrangi, PB Greer… - Physics in Medicine & …, 2018 - iopscience.iop.org
Over the past decade, the application of magnetic resonance imaging (MRI) has increased,
and there is growing evidence to suggest that improvements in the accuracy of target …

Computed tomography–based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression

CJ Galbán, MK Han, JL Boes, KA Chughtai… - Nature medicine, 2012 - nature.com
Chronic obstructive pulmonary disease (COPD) is increasingly being recognized as a highly
heterogeneous disorder, composed of varying pathobiology. Accurate detection of COPD …

[HTML][HTML] Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice

SC Thust, S Heiland, A Falini, HR Jäger… - European …, 2018 - Springer
Abstract Objectives At a European Society of Neuroradiology (ESNR) Annual Meeting 2015
workshop, commonalities in practice, current controversies and technical hurdles in glioma …

[HTML][HTML] The transformation of radiation oncology using real-time magnetic resonance guidance: A review

WA Hall, ES Paulson, UA van der Heide… - European Journal of …, 2019 - Elsevier
Radiation therapy (RT) is an essential component of effective cancer care and is used
across nearly all cancer types. The delivery of RT is becoming more precise through rapid …

Whole-body diffusion-weighted MR imaging in cancer: current status and research directions

AR Padhani, DM Koh, DJ Collins - Radiology, 2011 - pubs.rsna.org
Diffusion-weighted (DW) magnetic resonance (MR) imaging is emerging as a powerful
clinical tool for directing the care of patients with cancer. Whole-body DW imaging is almost …

Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods

R Ahmed, MJ Oborski, M Hwang… - Cancer management …, 2014 - Taylor & Francis
Malignant gliomas consist of glioblastomas, anaplastic astrocytomas, anaplastic
oligodendrogliomas and anaplastic oligoastrocytomas, and some less common tumors such …

Biomarkers of response and resistance to antiangiogenic therapy

RK Jain, DG Duda, CG Willett, DV Sahani… - Nature reviews Clinical …, 2009 - nature.com
No validated biological markers (or biomarkers) currently exist for appropriately selecting
patients with cancer for antiangiogenic therapy. Nor are there biomarkers identifying escape …

Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas

FG Dhermain, P Hau, H Lanfermann… - The Lancet …, 2010 - thelancet.com
Imaging techniques are important for accurate diagnosis and follow-up of patients with
gliomas. T1-weighted MRI, with or without gadolinium, is the gold standard method …

Predicting and monitoring cancer treatment response with diffusion‐weighted MRI

HC Thoeny, BD Ross - Journal of Magnetic Resonance Imaging, 2010 - Wiley Online Library
An imaging biomarker that would provide for an early quantitative metric of clinical treatment
response in cancer patients would provide for a paradigm shift in cancer care. Currently …